Akums Drugs and Pharmaceuticals IPO
Akums Drugs and Pharmaceuticals Limited (AKUMS) · mainboard IPO on NSE and BSE · 100% Book Building. Listed on 06 August 2024.
Issue details
Listing day
Back-tested estimate (from a model that had only seen earlier years' IPOs): listing gain +45.2% (likely range +32% to +64%), day's high +60.2%, chance of a gain 97%. Actual: +6.8% at the open, +17.4% at the high.
Subscription status
| Category | Shares offered | Shares bid for | Subscribed | |
|---|---|---|---|---|
| QIB (institutions) | 81,37,276 | 73,31,17,770 | 90.1x | |
| NII (HNI) total | 40,68,637 | 17,17,50,128 | 42.2x | |
| Big NII (above ₹10 lakh) | 27,12,425 | 12,86,49,664 | 47.4x | |
| Small NII (₹2-10 lakh) | 13,56,212 | 4,31,00,464 | 31.8x | |
| Retail | 27,12,424 | 5,77,70,020 | 21.3x | |
| Employees | 2,43,902 | 10,41,216 | 4.27x | |
| Total | 1,51,62,239 | 96,36,79,134 | 63.6x |
Bids on NSE and BSE together, as published by NSE, as of 01 Aug 2024, 07:00 PM. Shares offered exclude the anchor portion. 5% of all shares bid for were at the cut-off price.
Past IPOs with similar demand
Earlier mainboard IPOs whose QIB, NII and retail subscription and size were closest to Akums Drugs and Pharmaceuticals's, and how they listed.
| IPO | QIB | NII | Retail | Total | Size | Listing gain | Day high |
|---|---|---|---|---|---|---|---|
| TBO TekMay 2024 | 126x | 50.6x | 25.7x | 86.7x | ₹1,551 Cr | +55.0% | +58.3% |
| Apeejay Surrendra Park HotelsFeb 2024 | 75.1x | 52.4x | 30.4x | 59.7x | ₹971 Cr | +20.0% | +44.0% |
| INOX IndiaDec 2023 | 148x | 53.2x | 15.3x | 61.3x | ₹1,459 Cr | +43.9% | +50.0% |
| Credo Brands MarketingDec 2023 | 105x | 55.5x | 19.9x | 51.9x | ₹550 Cr | +0.8% | +16.0% |
| Bansal Wire IndustriesJul 2024 | 146x | 51.5x | 13.6x | 59.6x | ₹785 Cr | +39.1% | +45.3% |
| Innova CaptabDec 2023 | 117x | 64.9x | 17.1x | 55.3x | ₹577 Cr | +0.9% | +21.1% |
Lead managers and their listing record
| Book running lead manager | Mainboard IPOs since 2019 | Avg listing gain | Listed at a premium |
|---|---|---|---|
| ICICI Securities | 109 | +21.3% | 69% |
| Axis Capital | 107 | +20.4% | 73% |
| Citigroup Global Markets India | 35 | +14.2% | 63% |
| Ambit | 13 | +24.3% | 69% |
Offer documents (NSE)
Frequently asked
What is the Akums Drugs and Pharmaceuticals IPO price band and lot size? ₹646–679 per share, with a lot of 22 shares, so the smallest retail bid is ₹14,938.
How many times has it been subscribed? 63.6x overall: QIB 90.1x, NII 42.2x, retail 21.3x, employees 4.27x.
How did it list? It opened at ₹725, +6.8% against the issue price of ₹679, and closed its first day +17.3%.
